ArticleBioinformatics (Oxford, England)2026
NumMolFormer: an explicit functional group number-guided framework for structure-based drug design.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
motivationRational molecule generation that balances binding affinity with favorable physicochemical properties remains a formidable challenge in structure-based drug design. The number of functional groups is a key determinant, as over-functionalization compromises physicochemical properties, whereas under-functionalization reduces binding affinity. However, current methods are limited in their capacity to incorporate the constraint.
resultsTo address this, we present NumMolFormer, a Transformer-based framework designed to explicitly model functional group numbers. NumMolFormer adopts a dual-sequence input strategy, integrated with a numerical embedding module and a dual-stream differential attention mechanism, allowing molecular structures and functional group numbers to be encoded separately. This formulation alleviates the inherent limitations of standard Transformer in handling numerical information. In addition, we construct a large-scale dataset of 18 million molecules with functional group annotations for molecular pre-training, and further fine-tune the model using a combination of self-supervised learning and reinforcement learning under protein pocket constraints. The results demonstrate that NumMolFormer effectively leverages functional group information to generate molecules with improved binding affinity, synthetic accessibility, and drug-likeness compared to baseline methods. AVAILABILITY AND IMPLEMENTATION: The source code and datasets are available at http://www.github.com/zengzhicun/nummolformer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.